Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0606920200280020145
Biomolecules & Therapeutics
2020 Volume.28 No. 2 p.145 ~ p.151
Polyphenolic Biflavonoids Inhibit Amyloid-Beta Fibrillation and Disaggregate Preformed Amyloid-Beta Fibrils
Choi Erika Y.

Kang Sam-Sik
Lee Sang-Kook
Han Byung-Hee
Abstract
Alzheimer¡¯s disease (AD) is a devastating neurodegenerative disease and a major cause of dementia in elderly individuals worldwide. Increased deposition of insoluble amyloid ¥â (A¥â) fibrils in the brain is thought be a key neuropathological hallmark of AD. Many recent studies show that natural products such as polyphenolic flavonoids inhibit the formation of insoluble A¥â fibrils and/or destabilize ¥â-sheet-rich A¥â fibrils to form non-cytotoxic aggregates. In the present study, we explored the structure-activity relationship of naturally-occurring biflavonoids on A¥â amyloidogenesis utilizing an in vitro thioflavin T assay with A¥â1-42 peptide which is prone to aggregate more rapidly to fibrils than A¥â1-40 peptide. Among the biflavonoids we tested, we found amentoflavone revealed the most potent effects on inhibiting A¥â1-42 fibrillization (IC50: 0.26 ¥ìM), as well as on disassembling preformed A¥â1-42 fibrils (EC50: 0.59 ¥ìM). Our structure-activity relationship study suggests that the hydroxyl groups of biflavonoid compounds play an essential role in their molecular interaction with the dynamic process of A¥â1-42 fibrillization. Our atomic force microscopic imaging analysis demonstrates that amentoflavone directly disrupts the fibrillar structure of preformed A¥â1-42 fibrils, resulting in conversion of those fibrils to amorphous A¥â1-42 aggregates. These results indicate that amentoflavone affords the most potent anti-amyloidogenic effects on both inhibition of A¥â1-42 fibrillization and disaggregation of preformed mature A¥â1-42 fibrils.
KEYWORD
Alzheimer¡¯s disease, Amyloid ¥â (A¥â), Fibrillization, Disaggregation, Structure-activity relationship, Biflavonoids
FullTexts / Linksout information
 
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed